Company: LCTX
Filing Date: 2025-03-10
Form Type: 8-K
Source: 0000950170-25-036278
Chunk: 1

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press release issued March 10, 2025                                          
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                             Lineage Cell Therapeutics, Inc.          
  Date:      March 10, 2025      By:         /s/ George A. Samuel III                 
                                 Name:       George A. Samuel III